Rebuttal From Drs Viau-Lapointe and Fan

Chest. 2019 Apr;155(4):669-670. doi: 10.1016/j.chest.2018.11.021.

Authors

Julien Viau-Lapointe¹, Eddy Fan²

Affiliations

¹ Interdepartmental Division of Critical Care Medicine, University of Toronto; and Department of Medicine, Hôpital Maisonneuve-Rosemont, Université de Montréal, Montréal, QC, Canada.
² Interdepartmental Division of Critical Care Medicine, University of Toronto; and Department of Medicine, Hôpital Maisonneuve-Rosemont, Université de Montréal, Montréal, QC, Canada. Electronic address: eddy.fan@uhn.ca.

PMID: 30955571
DOI: 10.1016/j.chest.2018.11.021

No abstract available

Publication types

Editorial
Comment

MeSH terms

Epoprostenol*
Humans
Respiration
Respiratory Distress Syndrome*

Substances

Epoprostenol